Patents Assigned to Yeda Research & Development Co. Ltd. at the Weizmann Institute of Science
  • Patent number: 10933134
    Abstract: A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: March 2, 2021
    Assignees: Memorial Sloan Kettering Cancer Center, Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
    Inventors: Jonathan Coleman, Philip A. Watson, Kwanghee Kim, Avigdor Scherz
  • Patent number: 10463870
    Abstract: A system and methods for controlling pulse parameters during transcranial magnetic stimulation are provided. Multiple coils are placed on external body parts, and are controlled using an external control unit coupled to a stimulator having fast switches. The timing of the switches, as well as other parameters within the stimulator, determine the pulse parameters, such as pulse shape. The variety of pulse shapes obtainable using such a system and methods provides controlled physiologic effects within an internal body organ.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: November 5, 2019
    Assignee: Yeda Research & Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Yiftach Roth, Vadim Chudnovsky, Noach Safra, David Hazani, Abraham Zangen
  • Patent number: 10265412
    Abstract: The present invention relates in general to the field of enzyme replacement therapy, and specifically to chimeric proteins including protein hormone-therapeutic protein conjugates and fusion proteins, wherein the protein hormone is selected from a protein hormone which is able to cross the blood brain barrier, for the treatment of lysosomal storage diseases, compositions of the same and to methods of use thereof.
    Type: Grant
    Filed: February 6, 2007
    Date of Patent: April 23, 2019
    Assignees: Ramot at Tel-Aviv University Ltd., Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science, The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center
    Inventors: Naftali Stern, Ruth Navon, Anthony Futerman, Ari Zimran, Etty Osher
  • Patent number: 10238113
    Abstract: The present invention relates to regulation of ureide levels for optimal plant survival during nutrient remobilization such as occurs during normal growth, dark stress and senescence. Plants can be genetically engineered or selected using a suitable gene marker to have enhanced ureide accumulation. The present invention further provides methods of protecting plants, or extending the shelf life of fresh plant produce by application of exogenous ureides.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: March 26, 2019
    Assignees: Yeda Research and Development Co. Ltd. at The Weizmann Institute of Science, Ben-Gurion University of The Negev research and Development Authority
    Inventors: Robert Fluhr, Moshe Sagi
  • Patent number: 10159724
    Abstract: The present invention relates to a method for treating or preventing pathogenic infections in a subject having Cystic Fibrosis, COPD, and/or an open wound. This method involves selecting a subject having Cystic Fibrosis, COPD, and/or an open wound and administering to the selected subject a ceramidase under conditions effective to reduce ceramide and to treat or prevent the pathogenic infection. The method also involves the use of a ceramidase in combination with other drugs to reduce infection, reduce ceramide, or improve lung function in Cystic Fibrosis, COPD, and/or open wound patients.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: December 25, 2018
    Assignees: Icahn School of Medicine at Mount Sinai, Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Edward H. Schuchman, Erich Gulbins, Anthony Futerman, Yael Pewzner-Jung
  • Publication number: 20180223302
    Abstract: The present invention relates to an organism, a tissue, a cell or an organelle expressing enzymes which allow the conversion of 2-phosphoglycolate (2-PG; also known as glycolate 2-phosphate) into an intermediate compound of the Calvin-Benson-Bassham Cycle (CBBC) without releasing CO2. The organism, tissue, cell or organelle of the invention may be genetically engineered, transgenic and/or transplastomic so as to express at least one enzyme which is involved in this conversion. The present invention further relates to an organism, tissue, cell or organelle which comprises/expresses at least one enzyme which is involved in this conversion. The present invention further relates to a method for producing an organism, tissue, cell or organelle of the invention. The present invention further relates to a method of enzymatically converting 2-PG into an intermediate compound of the CBBC without releasing CO2.
    Type: Application
    Filed: June 22, 2016
    Publication date: August 9, 2018
    Applicants: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
    Inventors: Arren BAR-EVEN, Tobias ERB, Steffen LINDNER, Philippe MARLIERE, Dan S. TAWFIK
  • Patent number: 10029113
    Abstract: A system and methods for transcranial magnetic stimulation, the system including a helmet, a positioning portion, a stimulator and a cooling system, are disclosed. The helmet includes a coil for deep brain magnetic stimulation. The coil has a base portion, and return portions, which may include a protruding return portion and a contacting return portion. The coil is designed to minimize unintended stimulation of portions of the brain, while reducing accumulation of surface charges. The coil is stimulated at several locations and/or at different times so as to focus the electrical field on a specific deep neuronal structure.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: July 24, 2018
    Assignees: BRAINSWAY, LTD., YEDA RESEARCH & DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Abraham Zangen, Yiftach Roth, Pedro C. Miranda, David Hazani, Mark Hallett
  • Patent number: 9966458
    Abstract: The present invention relates to a method and a device for providing a current of spin-polarized electrons. More particularly, the present invention is suited for use in spin electronics or detection of spin-polarized electrons.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: May 8, 2018
    Assignees: Westfälische Wilhelms Universität Münster, Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Benjamin Göhler, Volker Hamelbeck, G. Friedrich Hanne, Helmut Zacharias, Ron Naaman, Tal Zvi Markus
  • Patent number: 9867576
    Abstract: Exemplary embodiments of a system and method can be provided for measuring a level and/or details of how engaging, effective or memorable a stimulus that may be based on information associated with one or more subjects' neuronal, physiological and/or behavioral responses to the stimulus. In addition, an exemplary embodiment of a computer-accessible medium containing executable instructions thereon can also be provided which can be executed by a processing arrangement. For example, when the processing arrangement executes the instructions, the processing arrangement can be configured to, e.g., receive neuronal, physiological and/or behavioral data one or more subjects being presented with stimuli, determine further data associated with a measure of inter-subject similarity of the neuronal, physiological and/or behavioral data, and identify particular portions of the stimuli that meet a pre-determined criteria relating to the further data associated with the measure of inter-subject similarity.
    Type: Grant
    Filed: November 9, 2015
    Date of Patent: January 16, 2018
    Assignees: NEW YORK UNIVERSITY, YEDA RESEARCH AND DEVELOPMENT CO., LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE
    Inventors: Uri Hasson, Rafi Malach, David Heeger
  • Patent number: 9802989
    Abstract: An isolated novel oil globule protein encoded by a polynucleotide sequence is provided together with a composition which includes the isolated protein. A transgenic organism transformed by a polynucleotide encoding a protein which at least partially comprises the amino acid sequence of the novel oil globule protein is also provided. The invention also provides a method for producing or enhancing the production of a carotenoid such as astaxanthin, which is an oil globule constituent.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: October 31, 2017
    Assignees: Ben Gurion University of the Negev Research and Development Authority, Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Sammy Boussiba, Ehud Peled, Uri Pick, Aliza Zarka, Stefan Lou, Meira Weiss
  • Patent number: 9631175
    Abstract: A method of generating neural and glial cells is provided. The method comprising growing human stem cells under conditions which induce differentiation of said human stem cells into the neural and glial cells, said conditions comprising the presence of retinoic acid and an agent capable of down-regulating Bone Morphogenic Protein activity.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: April 25, 2017
    Assignee: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Michel Revel, Judith Chebath, Michal Izrael, Rosalia Kaufman
  • Patent number: 9492514
    Abstract: The present invention relates to a method for treating or preventing pathogenic infections in a subject having Cystic Fibrosis, COPD, and/or an open wound. This method involves selecting a subject having Cystic Fibrosis, COPD, and/or an open wound and administering to the selected subject a ceramidase under conditions effective to reduce ceramide and to treat or prevent the pathogenic infection. The method also involves the use of a ceramidase in combination with other drugs to reduce infection, reduce ceramide, or improve lung function in Cystic Fibrosis, COPD, and/or open wound patients.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: November 15, 2016
    Assignees: Icahn School of Medicine at Mount Sinai, Universitaet Duisberg-Essen, Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Edward H. Schuchman, Erich Gulbins, Anthony Futerman, Yael Pewzner-Jung
  • Patent number: 9421393
    Abstract: A system and methods for controlling pulse parameters during transcranial magnetic stimulation are provided. Multiple coils are placed on external body parts, and are controlled using an external control unit coupled to a stimulator having fast switches. The timing of the switches, as well as other parameters within the stimulator, determine the pulse parameters, such as pulse shape. The variety of pulse shapes obtainable using such a system and methods provides controlled physiologic effects within an internal body organ.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: August 23, 2016
    Assignee: Yeda Research & Development Co., Ltd. at the Weizmann Institute of Science
    Inventors: Yiftach Roth, Vadim Chudnovsky, Noach Safra, David Hazani, Abraham Zangen
  • Patent number: 9391285
    Abstract: The present invention relates to a method and a device for providing a current of spin-polarized electrons. More particularly, the present invention is suited for use in spin electronics or detection of spin-polarized electrons.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: July 12, 2016
    Assignees: Westfälische Wilhelms Universität Münster, Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Benjamin Göhler, Volker Hamelbeck, G. Friedrich Hanne, Helmut Zacharias, Ron Naaman, Tal Zvi Markus
  • Patent number: 9345753
    Abstract: Compositions and methods for prevention and treatment of Alzheimer's disease utilize a combination of amyloid-beta protein or a fragment thereof and a heat shock protein or a fragment thereof.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: May 24, 2016
    Assignees: YEDA RESEARCH AND DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE, BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Alon Monsonego, Irun R. Cohen
  • Patent number: 9179858
    Abstract: Exemplary embodiments of a system and method can be provided for measuring a level and/or details of how engaging, effective or memorable a stimulus that may be based on information associated with one or more subjects' neuronal, physiological and/or behavioral responses to the stimulus. In addition, an exemplary embodiment of a computer-accessible medium containing executable instructions thereon can also be provided which can be executed by a processing arrangement. For example, when the processing arrangement executes the instructions, the processing arrangement can be configured to, e.g., receive neuronal, physiological and/or behavioral data one or more subjects being presented with stimuli, determine further data associated with a measure of inter-subject similarity of the neuronal, physiological and/or behavioral data, and identify particular portions of the stimuli that meet a pre-determined criteria relating to the further data associated with the measure of inter-subject similarity.
    Type: Grant
    Filed: March 5, 2009
    Date of Patent: November 10, 2015
    Assignees: New York University, Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Uri Hasson, Rafi Malach, David Heeger
  • Patent number: 9180305
    Abstract: A system and methods for controlling pulse parameters during transcranial magnetic stimulation are provided. Multiple coils are placed on external body parts, and are controlled using an external control unit coupled to a stimulator having fast switches. The timing of the switches, as well as other parameters within the stimulator, determine the pulse parameters, such as pulse shape. The variety of pulse shapes obtainable using such a system and methods provides controlled physiologic effects within an internal body organ.
    Type: Grant
    Filed: December 11, 2008
    Date of Patent: November 10, 2015
    Assignee: Yeda Research & Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Yiftach Roth, Abraham Zangen, Vadim Chudnovsky, Noach Safra, David Hazani
  • Publication number: 20150307883
    Abstract: Monomeric and multimeric aptamers are provided. Also provided are pharmaceutical compositions which comprise same and methods of using same.
    Type: Application
    Filed: October 27, 2013
    Publication date: October 29, 2015
    Applicant: Yeda Research and Development Co. Ltd. at Weizmann Institute of Science
    Inventors: Yosef YARDEN, Michael SELA, Georg MAHLKNECHT, Ruth MARON, Bilha SCHECHTER
  • Publication number: 20150290233
    Abstract: A method of preventing tumor metastasis with the proviso that the tumor is not glioma is provided. The method comprising administering to a subject in need thereof a therapeutically effective amount of an inhibitor of synaptojanin 2 (SYNJ2), thereby preventing tumor metastasis. Also, provided is a method of treating cancer. The method comprising, administering to a subject in need thereof a therapeutically effective amount of an inhibitor of synaptojanin 2 (SYNJ2) and an inhibitor of a cell surface receptor associated with an onset or progression of cancer, thereby treating cancer.
    Type: Application
    Filed: November 28, 2013
    Publication date: October 15, 2015
    Applicant: Yeda Research and Development Co.Ltd. at the Weizmann Institute of Science
    Inventors: Yosef Yarden, Nir Ben-Chetrit
  • Patent number: 9132278
    Abstract: A system and methods for transcranial magnetic stimulation, the system including a helmet, a positioning portion, a stimulator and a cooling system, are disclosed. The helmet includes a coil for deep brain magnetic stimulation. The coil has a base portion, and return portions, which may include a protruding return portion and a contacting return portion. The coil is designed to minimize unintended stimulation of portions of the brain, while reducing accumulation of surface charges. The coil is stimulated at several locations and/or at different times so as to focus the electrical field on a specific deep neuronal structure.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: September 15, 2015
    Assignees: BRAINSWAY, LTD., YEDA RESEARCH & DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Abraham Zangen, Yiftach Roth, Pedro C. Miranda, David Hazani, Mark Hallett